Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
To investigate daily cortisol production and clearance rates in a group (n = 18) of normal unstressed pubertal males, we applied deconvolution analysis to serum cortisol concentrations obtained every 20 min for 24 h. Subject-specific characterization of adrenocortical secretory episodes, cortisol production rate, and serum hormone half-life for nine early pubertal (Tanner I or II; early) and nine late pubertal (Tanner IV or V; late) subjects was undertaken to assess potential roles of sexual maturation and changing gonadal steroid hormone concentrations on glucocorticoid physiology. The estimated cortisol production rate for the early group [16.8 +/- 1.3 mumol/m2 x day (6.1 +/- 0.4 mg/m2 x day)] was indistinguishable from that of the late subjects [14.8 +/- 1.4 mumol/m2 x day (5.3 +/- 0.5 mg/m2 x day)]. No differences were observed between the two pubertal groups in the secretory burst frequency and half-duration, mass of cortisol released per secretory episode, average maximal rate of hormone secretion, and serum cortisol half-life. A significant diurnal pattern of cortisol secretion was observed for all subjects manifest by nyctohemeral variations in the frequency of adrenocortical secretory bursts, the amplitude (maximal rate of cortisol secretion) and the mass of cortisol released per secretory episode. Maximum serum hormone concentrations occurred between 0706 and 1114 h. We conclude that in normal pubertal males: 1) cortisol production rates as estimated by deconvolution analysis are in agreement with other recent independent isotopic estimates, but are lower than many previous estimates; 2) the rise in serum gonadal steroid hormone levels is unassociated with alterations in the production rate or metabolic clearance of cortisol; and 3) increased secretory burst frequency, increased amplitude (maximal rate of cortisol secretion attained within each secretory event), and increased mass of cortisol released per adrenocortical secretory episode give rise to the normal diurnal rhythm of circulating cortisol.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mean cortisol production rates are influenced by age and body composition and have been reported to be about 5-8 mg/m 2 /d (85-88), which is equivalent to an oral replacement with 15-25 mg/d (with a tendency toward the lower margin to avoid overtreatment) of hydrocortisone or 20 -35 mg of cortisone acetate in adults.”
From Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [87]
In the citing paper
“It is worth noting that during puberty daily requirement of HC can vary as a consequence of endogenous sexual steroids production, so that dose titration may be necessary (38).”
From X-linked adrenoleukodystrophy and primary adrenal insufficiency (2023) · cites this paper as [38]
Citations
Cites
Variations in the pattern of pubertal changes in boys
Marshall, W. A., & Tanner, J. M. (1970) · Archives of Disease in Childhood · doi:10.1136/adc.45.239.13 · Cited by 5,147
Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects
WEITZMAN, E. D., FUKUSHIMA, D., NOGEIRE, C., ROFFWARG, H., GALLAGHER, T. F., & HELLMAN, L. (1971) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-33-1-14 · Cited by 1,258
Clinical longitudinal standards for height and height velocity for North American children
Tanner, J. M., & Davies, P. S. W. (1985) · The Journal of Pediatrics · doi:10.1016/s0022-3476(85)80501-1 · Cited by 1,092
Standardized Percentile Curves of Body-Mass Index for Children and Adolescents
Hammer, L. D. (1991) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1991.02160030027015 · Cited by 571
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481
Spontaneous Growth Hormone Secretion Increases during Puberty in Normal Girls and Boys*
ROSE, S. R., MUNICCHI, G., BARNES, K. M., KAMP, G. A., URIARTE, M. M., ROSS, J. L., CASSORLA, F., & CUTLER, G. B. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-428 · Cited by 293
Martha, P. M., Gorman, K. M., Blizzard, R. M., Rogol, A. D., & Veldhuis, J. D. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.2.1730812 · Cited by 268
Self-citationBurke, C. W. (1985) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(85)80084-0 · Cited by 268
Veldhuis, J. D., Iranmanesh, A., Lizarralde, G., & Johnson, M. L. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.1.e6 · Cited by 224
Self-citationVELDHUIS, J. D., IRANMANESH, A., JOHNSON, M. L., & LIZARRALDE, G. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-2-452 · Cited by 205
Self-citation
Cited by
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
“These doses exceed physiological levels of cortisol secretion, which are 6–7 mg/M(2)/day in children and adolescents (244, 245).”
BackgroundCongenital Adrenal Hyperplasia
(1987) · New England Journal of Medicine · doi:10.1056/nejm198711263172211 · Cited by 1,409
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Arlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819
Davis, A. L., Carcillo, J. A., Aneja, R. K., Deymann, A. J., Lin, J. C., Nguyen, T. C., Okhuysen-Cawley, R. S., Relvas, M. S., Rozenfeld, R. A., Skippen, P. W., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002425 · Cited by 670
Congenital adrenal hyperplasia.
Merke, D. P., & Bornstein, S. R. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66736-0 · Cited by 628
Erichsen, M. M., Løvås, K., Skinningsrud, B., Wolff, A. B., Undlien, D. E., Svartberg, J., Fougner, K. J., Berg, T. J., Bollerslev, J., Mella, B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1368 · Cited by 422
“On the other hand, despite expert follow-up, the majority of the patients still use higher than recommended doses of glucocorticoids based on endogenous production (31, 32).”
BackgroundMortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Ten, S. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.7.2909 · Cited by 350
Kiess, W., Meidert, A., Dressendörfer, R. A., Schriever, K., Kessler, U., Köunig, A., Schwarz, H. P., & Strasburger, C. J. (1995) · Pediatric Research · doi:10.1203/00006450-199504000-00020 · Cited by 319
Adrenal insufficiency: still a cause of morbidity and death in childhood
Shulman, D. I., Palmert, M. R., Kemp, S. F., & for the Lawson Wilkins Drug and Therapeutics Committee (2007) · PEDIATRICS · doi:10.1542/peds.2006-1612 · Cited by 282
Review: Replication of cortisol circadian rhythm: new advances in hydrocortisone replacement therapy
Chan, S., & Debono, M. (2010) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018810380214 · Cited by 243
Somatotropic and Gonadotropic Axes Linkages in Infancy, Childhood, and the Puberty-Adult Transition
Veldhuis, J. D., Roemmich, J. N., Richmond, E. J., & Bowers, C. Y. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0006 · Cited by 236
Self-citationForest, M. G. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh047 · Cited by 200
Knutsson, U., Dahlgren, J., Marcus, C., Rosberg, S., Brönnegård, M., Stierna, P., & Albertsson-Wikland, K. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.2.3769 · Cited by 198
Sherlock, M., Reulen, R. C., Alonso, A. A., Ayuk, J., Clayton, R. N., Sheppard, M. C., Hawkins, M. M., Bates, A. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1097 · Cited by 185
Diurnal and Seasonal Cortisol, Testosterone, and DHEA Rhythms in Boys and Girls during Puberty
Matchock, R. L., Dorn, L. D., & Susman, E. J. (2007) · Chronobiology International · doi:10.1080/07420520701649471 · Cited by 175
Davis, S. N., Shavers, C., Costa, F., & Mosqueda-Garcia, R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118839 · Cited by 173
Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone
Løvås, K., Gjesdal, C. G., Christensen, M., Wolff, A. B., Almås, B., Svartberg, J., Fougner, K. J., Syversen, U., Bollerslev, J., Falch, J. A., et al. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0880 · Cited by 163
Continuous subcutaneous hydrocortisone infusion in Addison’s disease
Løvås, K., & Husebye, E. S. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0052 · Cited by 155
Koetz, K. R., Ventz, M., Diederich, S., & Quinkler, M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2036 · Cited by 139
Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy
Debono, M., Ross, R. J., & Newell-Price, J. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0874 · Cited by 135
Kraan, G. P. B., Dullaart, R. P. F., Pratt, J. J., Wolthers, B. G., Drayer, N. M., & de Bruin, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.4.4694 · Cited by 100
Bright, G. M. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883829 · Cited by 137
Why is the management of glucocorticoid deficiency still controversial: a review of the literature
Crown, A., & Lightman, S. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02320.x · Cited by 128
Øksnes, M., Björnsdottir, S., Isaksson, M., Methlie, P., Carlsen, S., Nilsen, R. M., Broman, J.-E., Triebner, K., Kämpe, O., Hulting, A.-L., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4253 · Cited by 134
Salivary Cortisol for Assessment of Hypothalamic-Pituitary-Adrenal Axis Function
Törnhage, C.-J. (2009) · Neuroimmunomodulation · doi:10.1159/000216186 · Cited by 118
Comparative Effect of Night and Daytime Sleep on the 24-Hour Cortisol Secretory Profile
(1995) · Sleep · doi:10.1093/sleep/18.7.549 · Cited by 110
Adrenal crisis: prevention and management in adult patients
Dineen, R., Thompson, C. J., & Sherlock, M. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819848218 · Cited by 123
Glucocorticoid-induced diabetes and adrenal suppression: How to detect and manage them
Lansang, M. C., & Hustak, L. K. (2011) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.78a.10180 · Cited by 105
Jung, C., Greco, S., Nguyen, H. H., Ho, J. T., Lewis, J. G., Torpy, D. J., & Inder, W. J. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-91 · Cited by 114
“7 mg/m(2)/day [4,5], or 9–11 mg/m(2)/day [6], leading to recommendations of a total daily replacement dose of 15–20 mg hydrocortisone [7,8].”
BackgroundCONGENITAL ADRENAL HYPERPLASIA OWING TO 21-HYDROXYLASE DEFICIENCY
Speiser, P. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70018-5 · Cited by 109
Stroud, L. R., Papandonatos, G. D., Williamson, D. E., & Dahl, R. E. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2011.02.017 · Cited by 99
Corticosteroid physiology and principles of therapy
Gupta, P., & Bhatia, V. (2008) · The Indian Journal of Pediatrics · doi:10.1007/s12098-008-0208-1 · Cited by 103
Mazziotti, G., Formenti, A. M., Frara, S., Roca, E., Mortini, P., Berruti, A., & Giustina, A. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0154 · Cited by 96
Newell‐Price, J., Whiteman, M., Rostami‐Hodjegan, A., Darzy, K., Shalet, S., Tucker, G. T., & Ross, R. J. M. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03011.x · Cited by 85
Chakhtoura, Z., Bachelot, A., Samara-Boustani, D., Ruiz, J.-C., Donadille, B., Dulon, J., Christin-Maître, S., Bouvattier, C., Raux-Demay, M.-C., Bouchard, P., et al. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0887 · Cited by 90
“Many studies have pointed out that normal endogenous cortisol production is around 7 mg/m2/d in healthy people (38, 39), whereas clinicians advocate 10 to 15 mg/m2/d of exogenous therapy (40), which can bring on corticosteroid side effects in bone and result in subnormal androgen levels.”
BackgroundGlucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma
Zueger, T., Kirchner, P., Herren, C., Fischli, S., Zwahlen, M., Christ, E., & Stettler, C. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2432 · Cited by 90
Endocrine manifestations of craniopharyngioma
Halac, I., & Zimmerman, D. (2005) · Child s Nervous System · doi:10.1007/s00381-005-1246-x · Cited by 87
Suzuki, M., Uchida, S., Ueda, K., Tobayama, T., Katsumata, E., Yoshioka, M., & Aida, K. (2003) · General and Comparative Endocrinology · doi:10.1016/s0016-6480(03)00100-x · Cited by 79
Metzger, D. L. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.2.458 · Cited by 73
Self-citationRandomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia
Silva, I. N., Kater, C. E., Cunha, C. D. F., & Viana, M. B. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.3.214 · Cited by 71
Internal dissociation of the circadian markers of the cortisol rhythm in night workers
Weibel, L., Spiegel, K., Follenius, M., Ehrhart, J., & Brandenberger, G. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.270.4.e608 · Cited by 68
Management of adrenal insufficiency during the stress of medical illness and surgery
Jung, C., & Inder, W. J. (2008) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2008.tb01686.x · Cited by 72
Danilowicz, K., Bruno, O. D., Manavela, M., Gomez, R. M., & Barkan, A. (2008) · Pituitary · doi:10.1007/s11102-008-0126-2 · Cited by 72
“Modern, more accurate, methodologies have found that the true cortisol secretion rates in humans (5– 7 mg/m) are less than half of the older estimates [19].”
BackgroundJarcho, M. R., Mendoza, S. P., Mason, W. A., Yang, X., & Bales, K. L. (2011) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2010.00677.x · Cited by 70
Hammarstrand, C., Ragnarsson, O., Hallén, T., Andersson, E., Skoglund, T., Nilsson, A. G., Johannsson, G., & Olsson, D. S. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0340 · Cited by 70
Autistic behavior in boys with fragile X syndrome: social approach and HPA-axis dysfunction
Roberts, J. E., Clarke, M. A., Alcorn, K., Carter, J. C., Long, A. C. J., & Kaufmann, W. E. (2009) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-009-9028-5 · Cited by 58
Novel strategies for hydrocortisone replacement
Debono, M., Price, J., & Ross, R. J. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.010 · Cited by 69
Nonclassic adrenal hyperplasia
Speiser, P. (2008) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9097-x · Cited by 68
Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency
Oprea, A., Bonnet, N., Pollé, O. G., & Lysy, P. A. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818821294 · Cited by 68
Miller, B. S., Spencer, S. P., Geffner, M. E., Gourgari, E., Lahoti, A., Kamboj, M. K., Stanley, T. L., Uli, N. K., Wicklow, B. A., & Sarafoglou, K. (2020) · Journal of Investigative Medicine · doi:10.1136/jim-2019-000999 · Cited by 49
Neuroendocrine Processes Underlying Ultradian Sleep Regulation in Man
Gronfier, C. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2686 · Cited by 61
Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits
Miller, W. L., & Witchel, S. F. (2013) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.10.885 · Cited by 62
Muirhead, S. E., Sellers, E. A. C., & Guyda, H. J. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.126601 · Cited by 62
Therapeutic management of adrenal insufficiency
Hahner, S., & Allolio, B. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2008.09.009 · Cited by 61
Wichers, M., Springer, W., Bidlingmaier, F., & Klingmüller, D. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00723.x · Cited by 53
Adrenal cortex and its disorders
Miller, W. L., & Flück, C. E. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00022-6 · Cited by 60
Huynh, T., McGown, I. N., Cowley, D. M., Nyunt, O., Leong, G. M., Harris, M. A., & Cotterill, A. M. (2009) · PubMed Central · Cited by 60
Corticotropin Secretory Dynamics in Humans under Low Glucocorticoid Feedback
Veldhuis, J. D. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.11.5554 · Cited by 56
Self-citationCircadian rhythms in plasma cortisone and cortisol and the cortisone/cortisol ratio
Nomura, S., Fujitaka, M., Sakura, N., & Ueda, K. (1997) · Clinica Chimica Acta · doi:10.1016/s0009-8981(97)00142-3 · Cited by 58
Fredman, R., & Tenenhaus, M. (2012) · Burns · doi:10.1016/j.burns.2012.09.020 · Cited by 57
van den Berg, G. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.12.3750 · Cited by 56
Self-citationWine, E., Aloi, M., Biervliet, S. V., Bronský, J., de Carpi, J. M., Gasparetto, M., Gianolio, L., Gordon, H., Hojsak, I., Hudson, A. S., et al. (2025) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/jpn3.70097 · Cited by 55
Caldato, M. C. F., Fernandes, V. T., & Kater, C. E. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500017 · Cited by 48
Hypertension in children with congenital adrenal hyperplasia
Maccabee‐Ryaboy, N., Thomas, W., Kyllo, J., Lteif, A., Petryk, A., Gonzalez‐Bolanos, M. T., Hindmarsh, P. C., & Sarafoglou, K. (2016) · Clinical Endocrinology · doi:10.1111/cen.13086 · Cited by 47
Abolished circadian rhythm of salivary cortisol in elite artistic gymnasts
Georgopoulos, N. A., Rottstein, L., Tsekouras, A., Theodoropoulou, A., Koukkou, E. G., Mylonas, P. G., Polykarpou, G., Lampropoulou, E., Iconomou, G., Léglise, M., et al. (2010) · Steroids · doi:10.1016/j.steroids.2010.10.013 · Cited by 54
Congenital adrenal hyperplasia – pharmacologic interventions from the prenatal phase to adulthood
Claahsen-van der Grinten, H. L., Stikkelbroeck, N. M. M. L., Otten, B. J., & Hermus, A. R. M. M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.004 · Cited by 53
Neuroendocrine mechanisms mediating awakening of the human gonadotropic axis in puberty
Veldhuis, J. D. (1996) · Pediatric Nephrology · doi:10.1007/bf00866767 · Cited by 53
Self-citationUltradian Cortisol Pulsatility Encodes a Distinct, Biologically Important Signal
McMaster, A., Jangani, M., Sommer, P., Han, N., Brass, A., Beesley, S., Lu, W., Berry, A., Loudon, A., Donn, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015766 · Cited by 48
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Challenges in treatment of patients with non-classic congenital adrenal hyperplasia
Adriaansen, B. P. H., Schröder, M. A. M., Span, P. N., Sweep, F. C. G. J., van Herwaarden, A. E., & der Grinten, H. L. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1064024 · Cited by 51
Management of adrenal insufficiency in different clinical settings
Hahner, S., & Allolio, B. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.14.2407 · Cited by 51
Napier, C., & Pearce, S. H. S. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.09.010 · Cited by 51
Gronfier, C., Luthringer, R., Follenius, M., Schaltenbrand, N., Macher, J. P., Muzet, A., & Brandenberger, G. (1997) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/s0013-4694(97)00013-1 · Cited by 50
“The same halflives of hormone elimination were used for all subjects (Kerrigan et al., 1993).”
MethodSuliman, A. M., Freaney, R., Smith, T. P., McBrinn, Y., Murray, B., & McKenna, T. J. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01860.x · Cited by 50
Subcutaneous pulsatile glucocorticoid replacement therapy
Russell, G. M., Durant, C., Ataya, A., Papastathi, C., Bhake, R., Woltersdorf, W., & Lightman, S. (2014) · Clinical Endocrinology · doi:10.1111/cen.12470 · Cited by 49
CONGENITAL ADRENAL HYPERPLASIA OWING TO 21-HYDROXYLASE DEFICIENCY
Migeon, C. J., & Wisniewski, A. B. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70026-4 · Cited by 48
Skov, J., Sundström, A., Ludvigsson, J. F., Kämpe, O., & Bensing, S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-02298 · Cited by 44
Tian, T., Young, C. B., Zhu, Y., Xu, J., He, Y., Chen, M., Lei, H. C., Jiang, M., Qiu, J., Chen, X., et al. (2021) · Biological Psychiatry · doi:10.1016/j.biopsych.2021.02.002 · Cited by 48
Mahachoklertwattana, P., Vilaiyuk, S., Hongeng, S., & Okascharoen, C. (2004) · The Journal of Pediatrics · doi:10.1016/s0022-3476(04)00233-1 · Cited by 47
Løvås, K., Thorsen, T. E., & Husebye, E. S. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03344183 · Cited by 46
Cortisol response to operative stress with anesthesia in healthy children
Taylor, L. K., Auchus, R. J., Baskin, L. S., & Miller, W. L. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2148 · Cited by 44
Assessing Cortisol Production in Preterm Infants: Do Not Dispose of the Nappies
Heckmann, M., Hartmann, M. F., Kampschulte, B., Gack, H., Bödeker, R., Gortner, L., & Wudy, S. A. (2005) · Pediatric Research · doi:10.1203/01.pdr.0000153947.51642.c1 · Cited by 43
Bowden, S. A., Connolly, A. M., Kinnett, K., & Zeitler, P. S. (2019) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180346 · Cited by 42
Gronfier, C., Chapotot, F., Weibel, L., Jouny, C., Piquard, F., & Brandenberger, G. (1998) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1998.275.1.e94 · Cited by 38
Current and Novel Treatment Strategies in Children with Congenital Adrenal Hyperplasia
Nordenström, A., Falhammar, H., & Lajić, S. (2022) · Hormone Research in Paediatrics · doi:10.1159/000522260 · Cited by 41
Hydrocortisone replacement therapy in children and adolescents with hypopituitarism
DeVile, C. J., & Stanhope, R. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2101025.x · Cited by 41
Fetal endocrine therapy for congenital adrenal hyperplasia should not be done
Miller, W. L. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.01.005 · Cited by 40
Guidelines for diagnosis and treatment of 21-hydroxylase deficiency (2014 revision)
Ishii, T., Anzo, M., Adachi, M., Onigata, K., Kusuda, S., Nagasaki, K., Harada, S., Horikawa, R., Minagawa, M., Minamitani, K., et al. (2015) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.24.77 · Cited by 40
Congenital Adrenal Hyperplasia: Epidemiology, Management and Practical Drug Treatment
Merke, D. P., & Kabbani, M. (2001) · Pediatric Drugs · doi:10.2165/00128072-200103080-00005 · Cited by 40
Replacement therapy for Addison's disease: recent developments
Løvås, K., & Husebye, E. S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.4.497 · Cited by 32
Long-term consequences of childhood-onset congenital adrenal hyperplasia
White, P. C., & Speiser, P. (2002) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2002.0198 · Cited by 40
Advances in electrochemical biosensor design for the detection of the stress biomarker cortisol
Weber, C. J., Clay, O. M., Lycan, R. E., Anderson, G. K., & Simoska, O. (2023) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-023-05047-1 · Cited by 38
Clinical guidelines for the diagnosis and treatment of 21-hydroxylase deficiency (2021 revision)
Ishii, T., Kashimada, K., Amano, N., Takasawa, K., Nakamura‐Utsunomiya, A., Yatsuga, S., Mukai, T., Ida, S., Isobe, M., Fukushi, M., et al. (2022) · Clinical Pediatric Endocrinology · doi:10.1297/cpe.2022-0009 · Cited by 37
Serum Cortisol Levels in Captive Killer Whale and Bottlenose Dolphin
Suzuki, M., Tobayama, T., Katsumata, E., Yoshioka, M., & Aida, K. (1998) · Fisheries Science · doi:10.2331/fishsci.64.643 · Cited by 37
The hypothalamic pituitary axis in the fetus and newborn
Brosnan, P. G. (2001) · Seminars in Perinatology · doi:10.1053/sper.2001.29038 · Cited by 37
Chantzichristos, D., Svensson, P.-A., Garner, T., Glad, C. A., Walker, B. R., Bergthorsdottir, R., Ragnarsson, O., Trimpou, P., Stimson, R. H., Borresen, S. W., et al. (2021) · eLife · doi:10.7554/elife.62236 · Cited by 36
Fine tuning for quality of life: 21st century approach to treatment of Addison’s disease
Reisch, N., & Arlt, W. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.01.008 · Cited by 36
Metadata
- Authors
- Kerrigan, J. R., Veldhuis, J. D., Leyo, S. A., Iranmanesh, A., & Rogol, A. D.
- Affiliations
- University of Virginia (US)
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1993-06
- Volume
- 76
- Issue
- 6
- Pages
- 1505-1510
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2116256519
- Cited by
- 228
- References
- 41
- Citations by year
- 2025: 3 · 2024: 2 · 2023: 6 · 2022: 7 · 2021: 5 · 2020: 9 · 2019: 7 · 2018: 5 · 2017: 10 · 2016: 6 · 2015: 8 · 2014: 10 · 2013: 5 · 2012: 10
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Virginia
- National Institutes of Health (5k04hd000634-02, 5k08hd000926-03)
- National Center for Research Resources (RR 00847, M01RR000847)
- NIH Clinical Center
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (RCDA 1KO4 HD 00634, HD-00926)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- cortisol production rate, cortisol clearance, sex steroids, sexual maturation, deconvolution
- MeSH terms
- Adolescent, Child, Circadian Rhythm, Humans, Hydrocortisone, Male, Metabolic Clearance Rate, Osmolar Concentration, Puberty, Reference Values, Time Factors, 17-Hydroxycorticosteroids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.